• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动对慢性心力衰竭患者血浆N末端B型利钠肽原的影响。

Effect of atrial fibrillation on plasma NT-proBNP in chronic heart failure.

作者信息

Corell Pernille, Gustafsson Finn, Kistorp Caroline, Madsen Lene Helleskov, Schou Morten, Hildebrandt Per

机构信息

Department of Cardiology and Endocrinology E, Frederiksberg University Hospital, Ndr. Fasanvej 57, 2000 Frederiksberg, Denmark.

出版信息

Int J Cardiol. 2007 May 2;117(3):395-402. doi: 10.1016/j.ijcard.2006.03.084. Epub 2006 Aug 17.

DOI:10.1016/j.ijcard.2006.03.084
PMID:16919342
Abstract

BACKGROUND

Brain natriuretic peptides are elevated in patients with systolic heart failure (HF) as well as in patients with atrial fibrillation (AF) and normal left ventricular ejection fraction (LVEF) and are strong predictors of death in HF patients. The aim of our study was to examine the levels of N-terminal pro brain natriuretic peptide (NT-proBNP) in patients with HF and AF versus HF and sinus rhythm (SR) and if NT-proBNP has prognostic influence in patients with AF.

METHODS

We included 245 patients (72% men, 70 years) with HF referred to a HF clinic. NT-proBNP was measured at referral (baseline).

RESULTS

At baseline, 26% had AF and at follow-up 35% of the surviving patients. Patients with AF were older than patients with SR (p=0.009), but LVEF and NYHA distribution were similar. Median NT-proBNP levels were higher: 2528 vs. 899 pg/ml (p<0.001). NT-proBNP was significantly correlated with AF at baseline (p<0.001), age (p=0.001), P-creatinine (p<0.001) and reduced LVEF (p=0.002). NT-proBNP was an independent predictor of death in patients with AF, adjusted HR 4.0 (95% CI 1.6-10.2) (p=0.003).

CONCLUSION

NT-proBNP levels are higher in HF patients with AF than in HF patients with SR and has prognostic value despite the presence of AF.

摘要

背景

脑钠肽在收缩性心力衰竭(HF)患者以及心房颤动(AF)且左心室射血分数(LVEF)正常的患者中升高,并且是HF患者死亡的强预测指标。我们研究的目的是检测HF合并AF患者与HF合并窦性心律(SR)患者的N末端脑钠肽原(NT-proBNP)水平,以及NT-proBNP对AF患者是否具有预后影响。

方法

我们纳入了245例转诊至HF门诊的HF患者(72%为男性,年龄70岁)。在转诊时(基线)测量NT-proBNP。

结果

基线时,26%的患者有AF,随访时存活患者中有35%有AF。AF患者比SR患者年龄更大(p=0.009),但LVEF和纽约心脏协会(NYHA)分级分布相似。NT-proBNP中位数水平更高:2528 vs. 899 pg/ml(p<0.001)。NT-proBNP在基线时与AF(p<0.001)、年龄(p=0.001)、血肌酐(p<0.001)和LVEF降低(p=0.002)显著相关。NT-proBNP是AF患者死亡的独立预测指标,校正后风险比为4.0(95%置信区间1.6-10.2)(p=0.003)。

结论

HF合并AF患者的NT-proBNP水平高于HF合并SR患者,并且尽管存在AF仍具有预后价值。

相似文献

1
Effect of atrial fibrillation on plasma NT-proBNP in chronic heart failure.心房颤动对慢性心力衰竭患者血浆N末端B型利钠肽原的影响。
Int J Cardiol. 2007 May 2;117(3):395-402. doi: 10.1016/j.ijcard.2006.03.084. Epub 2006 Aug 17.
2
Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.伴有和不伴有急性心力衰竭的呼吸困难患者中房颤与氨基末端脑钠肽前体浓度的关联:来自急诊科呼吸困难的脑钠肽前体研究(PRIDE)的结果
Am Heart J. 2007 Jan;153(1):90-7. doi: 10.1016/j.ahj.2006.10.005.
3
The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation.N端前B型利钠肽在检测心房颤动患者主要结构性心脏病中的诊断效用。
Eur Heart J. 2006 Oct;27(19):2353-61. doi: 10.1093/eurheartj/ehl233. Epub 2006 Sep 4.
4
Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.比较中段心房利钠肽原与N末端B型利钠肽原在预测慢性心力衰竭患者生存率中的作用
J Am Coll Cardiol. 2007 Nov 13;50(20):1973-80. doi: 10.1016/j.jacc.2007.08.012. Epub 2007 Oct 29.
5
Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP.心房颤动合并晚期慢性心力衰竭患者的利钠肽:(N端)心钠素(NT-ANP)和N末端B型利钠肽原(NT-proBNP)的决定因素及预后价值
Europace. 2006 Jul;8(7):482-7. doi: 10.1093/europace/eul060.
6
Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.左心室射血分数降低和保留的心力衰竭伴心房颤动患者的临床和预后影响。
Eur J Heart Fail. 2011 Oct;13(10):1111-20. doi: 10.1093/eurjhf/hfr066. Epub 2011 Jun 3.
7
[Changes in NT-proBNP levels in patients with atrial fibrillation related to heart failure].[心房颤动合并心力衰竭患者NT-脑钠肽水平的变化]
Vnitr Lek. 2010 Aug;56(8):788-94.
8
Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.比较 mid-regional pro-atrial natriuretic peptide 与 N-terminal pro B-type natriuretic peptide 在诊断心房颤动伴呼吸困难患者中的作用。
Heart. 2012 Oct;98(20):1518-22. doi: 10.1136/heartjnl-2012-302260. Epub 2012 Aug 3.
9
Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.N末端B型利钠肽原(NT-proBNP)在预测心力衰竭患者低功能状态、射血分数降低及心血管事件方面的临界值。
Cardiol J. 2009;16(1):43-9.
10
Discordant regulation of CRP and NT-proBNP plasma levels after electrical cardioversion of persistent atrial fibrillation.持续性心房颤动电复律后CRP和NT-proBNP血浆水平的不一致调节
Pacing Clin Electrophysiol. 2006 Jun;29(6):559-63. doi: 10.1111/j.1540-8159.2006.00401.x.

引用本文的文献

1
Comparison of Natriuretic Peptide Levels in Sinus Rhythm and Atrial Fibrillation in Acute Heart Failure.急性心力衰竭时窦性心律与心房颤动患者利钠肽水平的比较
Int J Heart Fail. 2025 Apr 24;7(2):85-95. doi: 10.36628/ijhf.2025.0007. eCollection 2025 Apr.
2
Screening for precapillary pulmonary hypertension in chronic myeloproliferative disorders: the role of N-terminal pro-B-type natriuretic peptide and vascular endothelial growth factor - a pilot study.慢性骨髓增殖性疾病中毛细血管前性肺动脉高压的筛查:N 端前 B 型利钠肽和血管内皮生长因子的作用——一项初步研究
Arch Med Sci. 2020 Feb 27;17(6):1628-1635. doi: 10.5114/aoms.2020.93315. eCollection 2021.
3
Prognostic value of natriuretic peptides in heart failure: systematic review and meta-analysis.
利钠肽在心力衰竭中的预后价值:系统评价与荟萃分析
Heart Fail Rev. 2022 Mar;27(2):645-654. doi: 10.1007/s10741-021-10136-3. Epub 2021 Jul 5.
4
N-terminal pro brain natriuretic peptide eliminates the prognostic effect of atrial fibrillation in patients with chronic heart failure.N-末端脑利钠肽前体消除了心房颤动对慢性心力衰竭患者的预后影响。
ESC Heart Fail. 2019 Aug;6(4):640-648. doi: 10.1002/ehf2.12464. Epub 2019 Jul 1.
5
Independent effect of atrial fibrillation on natriuretic peptide release.房颤对利钠肽释放的独立影响。
Clin Res Cardiol. 2019 Feb;108(2):142-149. doi: 10.1007/s00392-018-1332-1. Epub 2018 Jul 26.
6
Comparative accuracy of NT-proBNP and MR-proANP for the diagnosis of acute heart failure in dyspnoeic patients.NT-proBNP和MR-proANP在诊断呼吸困难患者急性心力衰竭中的比较准确性。
ESC Heart Fail. 2017 Aug;4(3):232-240. doi: 10.1002/ehf2.12150. Epub 2017 Apr 21.
7
BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure.B型利钠肽和N末端B型利钠肽原作为慢性稳定型心力衰竭患者的预后标志物
Heart Fail Rev. 2014 Aug;19(4):471-505. doi: 10.1007/s10741-014-9439-6.